Individual Differences of Multipotent Mesenchymal Stromal Cells Manifesting in during Interaction with Lymphocytes


Цитировать

Полный текст

Открытый доступ Открытый доступ
Доступ закрыт Доступ предоставлен
Доступ закрыт Только для подписчиков

Аннотация

Analysis of changes in lymphocyte subpopulations during co-culturing with multipotent mesenchymal stromal cells (MSC) revealed two distinct MSC groups: one group (A) increased HLA-DR expression on lymphocytes during co-culturing and the other (B) did not change it in comparison with lymphocyte monoculture. In stromal cells interacting with lymphocytes, expression of HLA-DR molecules was initiated, but only in samples that induced enhanced expression on lymphocytes and irrespectively of whether allogeneic or autologous lymphocytes were used for co-culturing with MSC. In group A, the relative expression of IDO1 significantly increased in comparison with group B. The revealed individual differences in MSC can explain why not all MSC samples are effective in the treatment of autoimmune diseases, acute “graft—versus—host” disease, and other pathologies.

Об авторах

N. Kapranov

National Research Center for Hematology, Ministry of Health of the Russian Federation

Email: ndrize@yandex.ru
Россия, Moscow

Yu. Davydova

National Research Center for Hematology, Ministry of Health of the Russian Federation

Email: ndrize@yandex.ru
Россия, Moscow

I. Gal’tseva

National Research Center for Hematology, Ministry of Health of the Russian Federation

Email: ndrize@yandex.ru
Россия, Moscow

N. Petinati

National Research Center for Hematology, Ministry of Health of the Russian Federation

Email: ndrize@yandex.ru
Россия, Moscow

N. Sats

National Research Center for Hematology, Ministry of Health of the Russian Federation

Email: ndrize@yandex.ru
Россия, Moscow

N. Drize

National Research Center for Hematology, Ministry of Health of the Russian Federation

Автор, ответственный за переписку.
Email: ndrize@yandex.ru
Россия, Moscow

L. Kuz’mina

National Research Center for Hematology, Ministry of Health of the Russian Federation

Email: ndrize@yandex.ru
Россия, Moscow

E. Parovichnikova

National Research Center for Hematology, Ministry of Health of the Russian Federation

Email: ndrize@yandex.ru
Россия, Moscow

V. Savchenko

National Research Center for Hematology, Ministry of Health of the Russian Federation

Email: ndrize@yandex.ru
Россия, Moscow


© Springer Science+Business Media, LLC, part of Springer Nature, 2018

Данный сайт использует cookie-файлы

Продолжая использовать наш сайт, вы даете согласие на обработку файлов cookie, которые обеспечивают правильную работу сайта.

О куки-файлах